3HYUK SANG YOO, TAE GWAN PARK. Biodegradable pol- ymeric micelles composed of doxorubicin conjugated PLGA- PEG block copolymer[J]. Journal of Controlled Release, 2001 (70) :63-70.
4HAIZHENG ZHAO, LIN YUE LANRY YUNG. Selectivity of folate conjugated polymer micelles against different tumor cells [J]. International Journal of Pharmaceutics, 2008 ( 349 ) : 256- z68.
2Barenberg SA,Sehultz JS,Anderson JM.et al.Hemocompatibility:macromolecular motions and order of the polymer interface.Trans Am Soc Artif Intern Organ,1979;25:159
3Lin SC.Preprints of the second international kyoto symposium of biomedical materials.Kyoto,Japan 1985:9
4Huang N,Yang P,Cheng X,et al.Blood compatibility of amorphous titanium oxide films synthesized by ion beam enhanced deposition.Biomaterils,1998;19(7-9):771
5中华人民共和国国家标准GB/T 16886.医疗器械生物学评价4-与血液相互作用试验选择
6Ji Hoon Jeong,Dong Woo Lim,Dong Keun Han,et al.Synthesis,characterization and protein adsorption behaviors of PLGA/PEG di-block co-polymer blend films.Colloids and Surfaces B:Biointerfaces,2000;18(3-4):371
7Luo W J, Li S M, Bei J Z et al. Synthesis and characterization of Poly(L-lactide)-poly(ethylene glycol) multibloek copolymers [J]. J Appl Polym Sei, 2002, 84(9): 1729-1736.
8Penco M, Marcioni S, Ferruti Pet al. Degradation behaviour of block copolymers containing poly(lactic-glycolic acid) and poly(ethylene glycol) segments [J]. Biomaterials, 1996, 17(16): 1583-1590.
9Fang C, Shi B, Pei Y Yet al. In vivo tumor targeting of tumor necrosis factor-a-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle size [J]. Eur J Pharm Sei, 2006, 27(1): 27-36.
10Lee C M, Choi Y, Huh E J e t al. Polyethylene glycol (PEG) modified 99mTc-HMPAO-liposome for improving blood circulation and biodistribution: The effect of the extent of PEGylation [J]. Cancer Biother Radio, 2005, 20(6): 620-628.
4Tosi G, Bortot B, Ruozi B, et al. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier [J]. Curr Med Chem, 2013, 20(17): 2212-2225.
5Goodenberger ML, Jenkins RB. Genetics of adult glioma[J]. Cancer Genet, 2012, 205(12): 613-621.
6Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems [J]. Colloids Surf B Biointerfaces, 2010, 75(1): 1-18.
7Ebbesen MF, Whitehead B, Ballarin-Gonzalez B, et al. Surface analysis of PEGylated nano-shields on nanoparticles installed by hydrophobic anchors[J]. Pharm Res, 2013, 30(7): 1758-1767.
8Chen YC, Hsieh WY, Lee WF, et al. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier[J]. J Biomater Appl, 2013, 27(7): 909-922.
9Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect[J]. Adv Drug Deliv Rev, 2011, 63(3): 170-183.
10Danhier F, Ansorena E, Silva JM, et al. PLGA-based nanoparticles: an overview of biomedical applications[J]. J Control Release, 2012, 161(2): 505-522.
